Alcon Inc. - Registered Shares (ALC)

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to

Market

Industry

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$39.2 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt.	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	$0.21 (0.27%)
1 Year Return Profit or loss of share price change plus dividend yield.	+23.0%
52-Week High Highest share price in the last 52 weeks.	$86.20
52-Week Low Lowest share price in the last 52 weeks.	$55.03
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return.	0.93
Outstanding Shares The number of shares the company has issued and are held by stockholders.	500 Million
Avg 30 Day Volume The number of shares traded in the last 30 days.	587 Thousand

Valuation

Compare to

Market

Industry

P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	-
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value.	$0.00
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	-
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	-
Enterprise Value to Revenue Enterprise value divided by revenue	-
Enterprise Value to EBIT Enterprise Value divided by EBIT	-
Total Debt to Enterprise Value Total debt divided by enterprise value	-
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	-

Profitability

Compare to

Market

Industry

Revenue Revenue is the sum of all cash flow into the company.	-
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services.	-
EBIT Earnings before tax and interest payments.	-
Net Income Net Income is the profit after all expenses have been deducted from the total revenue.	-
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	-
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	-
Return on Equity Equity divided by market cap.	-
Return on Assets Indicates a company's profitability in relation to its total assets.	-
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	-

Insider trades

Q4 2022 Q1 2023 Q2 2023 Q3 2023

About Alcon Inc. - Registered Shares

CEO: David J. Endicott

Employees: 20,000

Industry: Medical Specialties

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.

News

Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams | ALC Stock News

Alcon, the global leader in eye care dedicated to helping people see brilliantly, will present a robust lineup of scientific

Stock Titan, 20 days ago

Christina Ackermann Joins Verona Pharma as Non-Executive Director

LONDON and RALEIGH, N.C., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ: VRNA ) ("Verona Pharma"), announces effective September 1, 2023, Ms. C...

Benzinga, 26 days ago

JP Morgan upgrades Alcon to overweight in wake of earnings beat

JP Morgan’s European desk has upgraded Alcon (ALC) to overweight, commenting that concerns about growth in the implantables market is likely to be “short-liv...

Seeking Alpha, about 1 month ago